We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
101 hedge funds and large institutions have $734M invested in Revance Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
103% more call options, than puts
Call options by funds: $944K | Put options by funds: $466K
13% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 30
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 110 → 101 (-9)
14% less capital invested
Capital invested by funds: $854M → $734M (-$120M)
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
Holders
101
Holders Change
-9
Holders Change %
-8.18%
% of All Funds
2.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
34
Reduced
30
Closed
20
Calls
$944K
Puts
$466K
Net Calls
+$478K
Net Calls Change
+$339K
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$9.39M |
| 2 |
Renaissance Technologies
New York
|
+$8.71M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.23M |
| 5 |
JP Morgan Chase
New York
|
+$3.49M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.8M |
| 2 |
Millennium Management
New York
|
-$5.27M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.32M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.17M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.08M |
